Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol

Arzneimittelforschung. 1970 Aug;20(8):1119-25.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Asthenia / chemically induced
  • Benperidol / administration & dosage
  • Benperidol / adverse effects
  • Benperidol / therapeutic use*
  • Catatonia / drug therapy*
  • Clinical Trials as Topic
  • Depression / drug therapy*
  • Haloperidol / administration & dosage
  • Haloperidol / therapeutic use*
  • Humans
  • Hypertension / chemically induced
  • Male
  • Middle Aged
  • Paranoid Disorders / drug therapy*
  • Psychiatric Status Rating Scales
  • Psychopharmacology
  • Salivary Gland Diseases / chemically induced
  • Schizophrenia / drug therapy*
  • Tachycardia / chemically induced
  • Tremor / chemically induced
  • Vision Disorders / chemically induced

Substances

  • Benperidol
  • Haloperidol